Loading…

Selective Up-Regulation of Phosphodiesterase-4 Cyclic Adenosine 3′,5′-Monophosphate (cAMP)-Specific Phosphodiesterase Variants by Elevated cAMP Content in Human Myometrial Cells in Culture

In human myometrium, the modulation of intracellular cAMP content resulting from agonist-mediated stimulation of the receptor-adenylyl cyclase complex is largely influenced by the rate of cAMP hydrolysis by phosphodiesterase (PDE) isoenzymes. We have previously shown that the PDE4 family contributes...

Full description

Saved in:
Bibliographic Details
Published in:Endocrinology (Philadelphia) 1999-07, Vol.140 (7), p.3228-3237
Main Authors: Méhats, C, Tanguy, G, Dallot, E, Robert, B, Rebourcet, R, Ferré, F, Leroy, M. J
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c510t-f156824c96cd2ec0e81963938e0e85202cbcbad72b8d59b6e7f07fd7fabfbfab3
cites cdi_FETCH-LOGICAL-c510t-f156824c96cd2ec0e81963938e0e85202cbcbad72b8d59b6e7f07fd7fabfbfab3
container_end_page 3237
container_issue 7
container_start_page 3228
container_title Endocrinology (Philadelphia)
container_volume 140
creator Méhats, C
Tanguy, G
Dallot, E
Robert, B
Rebourcet, R
Ferré, F
Leroy, M. J
description In human myometrium, the modulation of intracellular cAMP content resulting from agonist-mediated stimulation of the receptor-adenylyl cyclase complex is largely influenced by the rate of cAMP hydrolysis by phosphodiesterase (PDE) isoenzymes. We have previously shown that the PDE4 family contributes to the predominant cAMP-hydrolyzing activity in human myometrium and that elevation of the PDE4B2 messenger RNA steady state level occurs in pregnant myometrial tissue. In the present study, we used a model of human myometrial cells in culture to determine whether an elevated cAMP concentration could influence PDE expression. As in myometrial tissue, high levels of PDE4 activity were detected in these smooth muscle cells. Long term treatment with 8-bromo-cAMP or forskolin resulted in a selective induction of PDE4B and of PDE4D short form messenger RNA variants. Concurrently, an increased immunoreactive signal for the PDE4B- and PDE4D-related isoenzymes was detected. This induction was consistent with an observed significant up-regulation of PDE4 activity. Accordingly, our results demonstrate that in human cultured myometrial cells, cAMP-elevating agents manipulate PDE4 activity through selective induction of synthesis of PDE4B and PDE4D short forms. Such a mechanism might have physiological importance during pregnancy by dampening hormonal stimulation and could thereby be involved in tolerance to the tocolytic effect of β-adrenoceptor agonists.
doi_str_mv 10.1210/endo.140.7.6847
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69852444</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1210/endo.140.7.6847</oup_id><sourcerecordid>3130518757</sourcerecordid><originalsourceid>FETCH-LOGICAL-c510t-f156824c96cd2ec0e81963938e0e85202cbcbad72b8d59b6e7f07fd7fabfbfab3</originalsourceid><addsrcrecordid>eNqNkc9qFTEUxoMo9vbq2p0EBKni3CbzLzPLy1BboReLtW5DJnPGpmSSMckU7s5n8gl8Fp-kGaegKIKbkxzO7_s4yYfQM0o2NKXkGExnNzQnG7Ypq5w9QCta50XCKCMP0YoQmiUsTdkBOvT-JrZ5nmeP0QElWVXktF6h75egQQZ1C_hqTD7A50mLoKzBtscX19aP17ZT4AM44SHJcbOXWkm87cBYrwzg7MfXb2-KWJKdNXb8KREB8JHc7i5eJZcjSNVHxV9m-JNwSpjgcbvHJxpuo6rDswo31gQwASuDz6ZBGLzb2wFCxDVuQGs_T5pJh8nBE_SoF9rD0_tzja7ennxszpLz96fvmu15IgtKQtLToqzSXNal7FKQBCpal1mdVRCvRUpS2cpWdCxtq66o2xJYT1jfsV60fRtLtkYvF9_R2S9TfAQflJdxGWHATp6XdbSZv3eNXvwB3tjJmbgbz2hGClqxgkXqeKGks9476Pno1CDcnlPC52j5HC2P0XLG52ij4vm979QO0P3GL1lG4PUC2Gn8D7dygeeBdDHJ0YH3v3b9l_AOirbExQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3130518757</pqid></control><display><type>article</type><title>Selective Up-Regulation of Phosphodiesterase-4 Cyclic Adenosine 3′,5′-Monophosphate (cAMP)-Specific Phosphodiesterase Variants by Elevated cAMP Content in Human Myometrial Cells in Culture</title><source>Oxford Journals Online</source><creator>Méhats, C ; Tanguy, G ; Dallot, E ; Robert, B ; Rebourcet, R ; Ferré, F ; Leroy, M. J</creator><creatorcontrib>Méhats, C ; Tanguy, G ; Dallot, E ; Robert, B ; Rebourcet, R ; Ferré, F ; Leroy, M. J</creatorcontrib><description>In human myometrium, the modulation of intracellular cAMP content resulting from agonist-mediated stimulation of the receptor-adenylyl cyclase complex is largely influenced by the rate of cAMP hydrolysis by phosphodiesterase (PDE) isoenzymes. We have previously shown that the PDE4 family contributes to the predominant cAMP-hydrolyzing activity in human myometrium and that elevation of the PDE4B2 messenger RNA steady state level occurs in pregnant myometrial tissue. In the present study, we used a model of human myometrial cells in culture to determine whether an elevated cAMP concentration could influence PDE expression. As in myometrial tissue, high levels of PDE4 activity were detected in these smooth muscle cells. Long term treatment with 8-bromo-cAMP or forskolin resulted in a selective induction of PDE4B and of PDE4D short form messenger RNA variants. Concurrently, an increased immunoreactive signal for the PDE4B- and PDE4D-related isoenzymes was detected. This induction was consistent with an observed significant up-regulation of PDE4 activity. Accordingly, our results demonstrate that in human cultured myometrial cells, cAMP-elevating agents manipulate PDE4 activity through selective induction of synthesis of PDE4B and PDE4D short forms. Such a mechanism might have physiological importance during pregnancy by dampening hormonal stimulation and could thereby be involved in tolerance to the tocolytic effect of β-adrenoceptor agonists.</description><identifier>ISSN: 0013-7227</identifier><identifier>EISSN: 1945-7170</identifier><identifier>DOI: 10.1210/endo.140.7.6847</identifier><identifier>PMID: 10385419</identifier><language>eng</language><publisher>United States: Endocrine Society</publisher><subject>3',5'-Cyclic-AMP Phosphodiesterases - genetics ; 3',5'-Cyclic-AMP Phosphodiesterases - metabolism ; 8-Bromo Cyclic Adenosine Monophosphate - pharmacology ; Adenosine ; Adenylate cyclase ; Adrenergic receptors ; Agonists ; Cell culture ; Cells, Cultured ; Colforsin - pharmacology ; Cyclic AMP ; Cyclic AMP - metabolism ; Cyclic Nucleotide Phosphodiesterases, Type 3 ; Cyclic Nucleotide Phosphodiesterases, Type 4 ; Cycloheximide - pharmacology ; Dactinomycin - pharmacology ; Enzyme Induction - physiology ; Female ; Forskolin ; Gene expression ; Homeostasis - physiology ; Humans ; Immunoblotting ; Isoenzymes ; Isoenzymes - metabolism ; Myometrium ; Myometrium - cytology ; Myometrium - drug effects ; Myometrium - metabolism ; Nucleic Acid Synthesis Inhibitors - pharmacology ; Osmolar Concentration ; Phosphodiesterase ; Physiological effects ; Protein Synthesis Inhibitors - pharmacology ; RNA, Messenger - metabolism ; Smooth muscle ; Stimulation ; Time Factors ; Tissue culture ; Up-regulation</subject><ispartof>Endocrinology (Philadelphia), 1999-07, Vol.140 (7), p.3228-3237</ispartof><rights>Copyright © 1999 by The Endocrine Society 1999</rights><rights>Copyright © 1999 by The Endocrine Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c510t-f156824c96cd2ec0e81963938e0e85202cbcbad72b8d59b6e7f07fd7fabfbfab3</citedby><cites>FETCH-LOGICAL-c510t-f156824c96cd2ec0e81963938e0e85202cbcbad72b8d59b6e7f07fd7fabfbfab3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10385419$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Méhats, C</creatorcontrib><creatorcontrib>Tanguy, G</creatorcontrib><creatorcontrib>Dallot, E</creatorcontrib><creatorcontrib>Robert, B</creatorcontrib><creatorcontrib>Rebourcet, R</creatorcontrib><creatorcontrib>Ferré, F</creatorcontrib><creatorcontrib>Leroy, M. J</creatorcontrib><title>Selective Up-Regulation of Phosphodiesterase-4 Cyclic Adenosine 3′,5′-Monophosphate (cAMP)-Specific Phosphodiesterase Variants by Elevated cAMP Content in Human Myometrial Cells in Culture</title><title>Endocrinology (Philadelphia)</title><addtitle>Endocrinology</addtitle><description>In human myometrium, the modulation of intracellular cAMP content resulting from agonist-mediated stimulation of the receptor-adenylyl cyclase complex is largely influenced by the rate of cAMP hydrolysis by phosphodiesterase (PDE) isoenzymes. We have previously shown that the PDE4 family contributes to the predominant cAMP-hydrolyzing activity in human myometrium and that elevation of the PDE4B2 messenger RNA steady state level occurs in pregnant myometrial tissue. In the present study, we used a model of human myometrial cells in culture to determine whether an elevated cAMP concentration could influence PDE expression. As in myometrial tissue, high levels of PDE4 activity were detected in these smooth muscle cells. Long term treatment with 8-bromo-cAMP or forskolin resulted in a selective induction of PDE4B and of PDE4D short form messenger RNA variants. Concurrently, an increased immunoreactive signal for the PDE4B- and PDE4D-related isoenzymes was detected. This induction was consistent with an observed significant up-regulation of PDE4 activity. Accordingly, our results demonstrate that in human cultured myometrial cells, cAMP-elevating agents manipulate PDE4 activity through selective induction of synthesis of PDE4B and PDE4D short forms. Such a mechanism might have physiological importance during pregnancy by dampening hormonal stimulation and could thereby be involved in tolerance to the tocolytic effect of β-adrenoceptor agonists.</description><subject>3',5'-Cyclic-AMP Phosphodiesterases - genetics</subject><subject>3',5'-Cyclic-AMP Phosphodiesterases - metabolism</subject><subject>8-Bromo Cyclic Adenosine Monophosphate - pharmacology</subject><subject>Adenosine</subject><subject>Adenylate cyclase</subject><subject>Adrenergic receptors</subject><subject>Agonists</subject><subject>Cell culture</subject><subject>Cells, Cultured</subject><subject>Colforsin - pharmacology</subject><subject>Cyclic AMP</subject><subject>Cyclic AMP - metabolism</subject><subject>Cyclic Nucleotide Phosphodiesterases, Type 3</subject><subject>Cyclic Nucleotide Phosphodiesterases, Type 4</subject><subject>Cycloheximide - pharmacology</subject><subject>Dactinomycin - pharmacology</subject><subject>Enzyme Induction - physiology</subject><subject>Female</subject><subject>Forskolin</subject><subject>Gene expression</subject><subject>Homeostasis - physiology</subject><subject>Humans</subject><subject>Immunoblotting</subject><subject>Isoenzymes</subject><subject>Isoenzymes - metabolism</subject><subject>Myometrium</subject><subject>Myometrium - cytology</subject><subject>Myometrium - drug effects</subject><subject>Myometrium - metabolism</subject><subject>Nucleic Acid Synthesis Inhibitors - pharmacology</subject><subject>Osmolar Concentration</subject><subject>Phosphodiesterase</subject><subject>Physiological effects</subject><subject>Protein Synthesis Inhibitors - pharmacology</subject><subject>RNA, Messenger - metabolism</subject><subject>Smooth muscle</subject><subject>Stimulation</subject><subject>Time Factors</subject><subject>Tissue culture</subject><subject>Up-regulation</subject><issn>0013-7227</issn><issn>1945-7170</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqNkc9qFTEUxoMo9vbq2p0EBKni3CbzLzPLy1BboReLtW5DJnPGpmSSMckU7s5n8gl8Fp-kGaegKIKbkxzO7_s4yYfQM0o2NKXkGExnNzQnG7Ypq5w9QCta50XCKCMP0YoQmiUsTdkBOvT-JrZ5nmeP0QElWVXktF6h75egQQZ1C_hqTD7A50mLoKzBtscX19aP17ZT4AM44SHJcbOXWkm87cBYrwzg7MfXb2-KWJKdNXb8KREB8JHc7i5eJZcjSNVHxV9m-JNwSpjgcbvHJxpuo6rDswo31gQwASuDz6ZBGLzb2wFCxDVuQGs_T5pJh8nBE_SoF9rD0_tzja7ennxszpLz96fvmu15IgtKQtLToqzSXNal7FKQBCpal1mdVRCvRUpS2cpWdCxtq66o2xJYT1jfsV60fRtLtkYvF9_R2S9TfAQflJdxGWHATp6XdbSZv3eNXvwB3tjJmbgbz2hGClqxgkXqeKGks9476Pno1CDcnlPC52j5HC2P0XLG52ij4vm979QO0P3GL1lG4PUC2Gn8D7dygeeBdDHJ0YH3v3b9l_AOirbExQ</recordid><startdate>19990701</startdate><enddate>19990701</enddate><creator>Méhats, C</creator><creator>Tanguy, G</creator><creator>Dallot, E</creator><creator>Robert, B</creator><creator>Rebourcet, R</creator><creator>Ferré, F</creator><creator>Leroy, M. J</creator><general>Endocrine Society</general><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19990701</creationdate><title>Selective Up-Regulation of Phosphodiesterase-4 Cyclic Adenosine 3′,5′-Monophosphate (cAMP)-Specific Phosphodiesterase Variants by Elevated cAMP Content in Human Myometrial Cells in Culture</title><author>Méhats, C ; Tanguy, G ; Dallot, E ; Robert, B ; Rebourcet, R ; Ferré, F ; Leroy, M. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c510t-f156824c96cd2ec0e81963938e0e85202cbcbad72b8d59b6e7f07fd7fabfbfab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>3',5'-Cyclic-AMP Phosphodiesterases - genetics</topic><topic>3',5'-Cyclic-AMP Phosphodiesterases - metabolism</topic><topic>8-Bromo Cyclic Adenosine Monophosphate - pharmacology</topic><topic>Adenosine</topic><topic>Adenylate cyclase</topic><topic>Adrenergic receptors</topic><topic>Agonists</topic><topic>Cell culture</topic><topic>Cells, Cultured</topic><topic>Colforsin - pharmacology</topic><topic>Cyclic AMP</topic><topic>Cyclic AMP - metabolism</topic><topic>Cyclic Nucleotide Phosphodiesterases, Type 3</topic><topic>Cyclic Nucleotide Phosphodiesterases, Type 4</topic><topic>Cycloheximide - pharmacology</topic><topic>Dactinomycin - pharmacology</topic><topic>Enzyme Induction - physiology</topic><topic>Female</topic><topic>Forskolin</topic><topic>Gene expression</topic><topic>Homeostasis - physiology</topic><topic>Humans</topic><topic>Immunoblotting</topic><topic>Isoenzymes</topic><topic>Isoenzymes - metabolism</topic><topic>Myometrium</topic><topic>Myometrium - cytology</topic><topic>Myometrium - drug effects</topic><topic>Myometrium - metabolism</topic><topic>Nucleic Acid Synthesis Inhibitors - pharmacology</topic><topic>Osmolar Concentration</topic><topic>Phosphodiesterase</topic><topic>Physiological effects</topic><topic>Protein Synthesis Inhibitors - pharmacology</topic><topic>RNA, Messenger - metabolism</topic><topic>Smooth muscle</topic><topic>Stimulation</topic><topic>Time Factors</topic><topic>Tissue culture</topic><topic>Up-regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Méhats, C</creatorcontrib><creatorcontrib>Tanguy, G</creatorcontrib><creatorcontrib>Dallot, E</creatorcontrib><creatorcontrib>Robert, B</creatorcontrib><creatorcontrib>Rebourcet, R</creatorcontrib><creatorcontrib>Ferré, F</creatorcontrib><creatorcontrib>Leroy, M. J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrinology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Méhats, C</au><au>Tanguy, G</au><au>Dallot, E</au><au>Robert, B</au><au>Rebourcet, R</au><au>Ferré, F</au><au>Leroy, M. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Selective Up-Regulation of Phosphodiesterase-4 Cyclic Adenosine 3′,5′-Monophosphate (cAMP)-Specific Phosphodiesterase Variants by Elevated cAMP Content in Human Myometrial Cells in Culture</atitle><jtitle>Endocrinology (Philadelphia)</jtitle><addtitle>Endocrinology</addtitle><date>1999-07-01</date><risdate>1999</risdate><volume>140</volume><issue>7</issue><spage>3228</spage><epage>3237</epage><pages>3228-3237</pages><issn>0013-7227</issn><eissn>1945-7170</eissn><abstract>In human myometrium, the modulation of intracellular cAMP content resulting from agonist-mediated stimulation of the receptor-adenylyl cyclase complex is largely influenced by the rate of cAMP hydrolysis by phosphodiesterase (PDE) isoenzymes. We have previously shown that the PDE4 family contributes to the predominant cAMP-hydrolyzing activity in human myometrium and that elevation of the PDE4B2 messenger RNA steady state level occurs in pregnant myometrial tissue. In the present study, we used a model of human myometrial cells in culture to determine whether an elevated cAMP concentration could influence PDE expression. As in myometrial tissue, high levels of PDE4 activity were detected in these smooth muscle cells. Long term treatment with 8-bromo-cAMP or forskolin resulted in a selective induction of PDE4B and of PDE4D short form messenger RNA variants. Concurrently, an increased immunoreactive signal for the PDE4B- and PDE4D-related isoenzymes was detected. This induction was consistent with an observed significant up-regulation of PDE4 activity. Accordingly, our results demonstrate that in human cultured myometrial cells, cAMP-elevating agents manipulate PDE4 activity through selective induction of synthesis of PDE4B and PDE4D short forms. Such a mechanism might have physiological importance during pregnancy by dampening hormonal stimulation and could thereby be involved in tolerance to the tocolytic effect of β-adrenoceptor agonists.</abstract><cop>United States</cop><pub>Endocrine Society</pub><pmid>10385419</pmid><doi>10.1210/endo.140.7.6847</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0013-7227
ispartof Endocrinology (Philadelphia), 1999-07, Vol.140 (7), p.3228-3237
issn 0013-7227
1945-7170
language eng
recordid cdi_proquest_miscellaneous_69852444
source Oxford Journals Online
subjects 3',5'-Cyclic-AMP Phosphodiesterases - genetics
3',5'-Cyclic-AMP Phosphodiesterases - metabolism
8-Bromo Cyclic Adenosine Monophosphate - pharmacology
Adenosine
Adenylate cyclase
Adrenergic receptors
Agonists
Cell culture
Cells, Cultured
Colforsin - pharmacology
Cyclic AMP
Cyclic AMP - metabolism
Cyclic Nucleotide Phosphodiesterases, Type 3
Cyclic Nucleotide Phosphodiesterases, Type 4
Cycloheximide - pharmacology
Dactinomycin - pharmacology
Enzyme Induction - physiology
Female
Forskolin
Gene expression
Homeostasis - physiology
Humans
Immunoblotting
Isoenzymes
Isoenzymes - metabolism
Myometrium
Myometrium - cytology
Myometrium - drug effects
Myometrium - metabolism
Nucleic Acid Synthesis Inhibitors - pharmacology
Osmolar Concentration
Phosphodiesterase
Physiological effects
Protein Synthesis Inhibitors - pharmacology
RNA, Messenger - metabolism
Smooth muscle
Stimulation
Time Factors
Tissue culture
Up-regulation
title Selective Up-Regulation of Phosphodiesterase-4 Cyclic Adenosine 3′,5′-Monophosphate (cAMP)-Specific Phosphodiesterase Variants by Elevated cAMP Content in Human Myometrial Cells in Culture
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T09%3A49%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Selective%20Up-Regulation%20of%20Phosphodiesterase-4%20Cyclic%20Adenosine%203%E2%80%B2,5%E2%80%B2-Monophosphate%20(cAMP)-Specific%20Phosphodiesterase%20Variants%20by%20Elevated%20cAMP%20Content%20in%20Human%20Myometrial%20Cells%20in%20Culture&rft.jtitle=Endocrinology%20(Philadelphia)&rft.au=Me%CC%81hats,%20C&rft.date=1999-07-01&rft.volume=140&rft.issue=7&rft.spage=3228&rft.epage=3237&rft.pages=3228-3237&rft.issn=0013-7227&rft.eissn=1945-7170&rft_id=info:doi/10.1210/endo.140.7.6847&rft_dat=%3Cproquest_cross%3E3130518757%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c510t-f156824c96cd2ec0e81963938e0e85202cbcbad72b8d59b6e7f07fd7fabfbfab3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3130518757&rft_id=info:pmid/10385419&rft_oup_id=10.1210/endo.140.7.6847&rfr_iscdi=true